Home » Newsletters » BioWorld Asia

BioWorld Asia

Aug. 19, 1998

View Archived Issues

Xenova, With Funds To Last Through 1998, Seeks Investors

British Biotech Woes Push UK To Consider Tighter Industry Controls

MorphoSys Changes Partners; Plans Public Offering In '98

Canada To Involve Nation In Debate On Biotech Issues

Display Systems Biotech Seeks Higher US Profile

Amrad Suspends Clinical Trial Of Reformulated Anesthetic

Research Institutes Spawn Many Australian Biotech Firms

French Study Shows Urokinase May Inhibit Growth Of Cancer

Clal Invests $10M In D-Pharm; Takes First Step Into Biotech

Appligène Reports 2Q Sales Increased Over Last Year

European Consumer Group Wants Aggressive GMO Food Labeling

D-Pharm Gets US Patent For Neuroprotective Agents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.